← Every applicant
Ingenus Pharms LLC FDA Approvals
15 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.
Newest first
A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.
| Product |
|---|
| DEHYDRATED ALCOHOLNew drugJul 9, 2025SOLUTION, INTRA-ARTERIAL |
| MESNANew drugJan 13, 2025TABLET, ORAL |
| LIFITEGRASTNew drugOct 3, 2024SOLUTION/DROPS, OPHTHALMIC |
| TAFLUPROSTNew drugApr 5, 2024SOLUTION/DROPS, OPHTHALMIC |
| BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDENew drugJul 3, 2023CAPSULE, ORAL |
| DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATENew drugMay 1, 2023SOLUTION/DROPS, OPHTHALMIC |
| CARBAMAZEPINENew drugDec 2, 2022TABLET, EXTENDED RELEASE, ORAL |
| DICLOFENAC SODIUMNew drugSep 23, 2022TABLET, EXTENDED RELEASE, ORAL |
| TIMOLOL MALEATENew drugSep 13, 2022SOLUTION/DROPS, OPHTHALMIC |
| CARMUSTINENew drugJun 21, 2022INJECTABLE, INJECTION |
| ISOSORBIDE DINITRATE AND HYDRALAZINE HYDROCHLORIDENew drugApr 6, 2022TABLET, ORAL |
| IVABRADINE HYDROCHLORIDENew drugDec 30, 2021TABLET, ORAL |
| BUTALBITAL, ACETAMINOPHEN AND CAFFEINENew drugNov 17, 2021CAPSULE, ORAL |
| DICLOFENAC POTASSIUMNew drugOct 8, 2021TABLET, ORAL |
| MEXILETINE HYDROCHLORIDENew drugJan 25, 2021CAPSULE, ORAL |